Geneva Partners LLC Sells 1,024 Shares of Lam Research Co. (NASDAQ:LRCX)

Geneva Partners LLC trimmed its holdings in shares of Lam Research Co. (NASDAQ:LRCX - Free Report) by 46.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 1,200 shares of the semiconductor company's stock after selling 1,024 shares during the period. Geneva Partners LLC's holdings in Lam Research were worth $940,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LRCX. Orion Capital Management LLC purchased a new stake in Lam Research during the 3rd quarter valued at $25,000. BluePath Capital Management LLC bought a new position in Lam Research during the 3rd quarter valued at about $28,000. OFI Invest Asset Management purchased a new stake in shares of Lam Research during the 3rd quarter valued at about $30,000. Asset Dedication LLC grew its stake in shares of Lam Research by 56.7% in the third quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company's stock worth $30,000 after acquiring an additional 17 shares during the period. Finally, Valued Wealth Advisors LLC purchased a new position in shares of Lam Research during the fourth quarter valued at approximately $30,000. Institutional investors own 84.61% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on LRCX shares. Raymond James increased their price target on Lam Research from $850.00 to $950.00 and gave the company an "outperform" rating in a report on Thursday, January 25th. TD Cowen boosted their price objective on shares of Lam Research from $710.00 to $975.00 and gave the company an "outperform" rating in a research report on Thursday, January 25th. Evercore ISI began coverage on Lam Research in a research report on Tuesday. They set an "outperform" rating and a $1,200.00 target price on the stock. The Goldman Sachs Group lifted their price objective on Lam Research from $700.00 to $912.00 and gave the company a "buy" rating in a research report on Thursday, January 25th. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on shares of Lam Research in a research note on Thursday, April 11th. They issued a "hold" rating and a $1,000.00 price objective for the company. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $899.64.

Insider Activity

In other Lam Research news, SVP Seshasayee Varadarajan sold 5,500 shares of the business's stock in a transaction on Monday, March 18th. The shares were sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the transaction, the senior vice president now owns 22,095 shares in the company, valued at $20,380,648.95. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Abhijit Y. Talwalkar sold 882 shares of the firm's stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $972.03, for a total transaction of $857,330.46. Following the completion of the sale, the director now directly owns 10,541 shares of the company's stock, valued at approximately $10,246,168.23. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Seshasayee Varadarajan sold 5,500 shares of the business's stock in a transaction on Monday, March 18th. The shares were sold at an average price of $922.41, for a total value of $5,073,255.00. Following the transaction, the senior vice president now owns 22,095 shares of the company's stock, valued at approximately $20,380,648.95. The disclosure for this sale can be found here. Insiders sold 7,029 shares of company stock valued at $6,559,489 in the last ninety days. Insiders own 0.32% of the company's stock.

Lam Research Price Performance

Shares of LRCX stock traded down $18.67 on Friday, reaching $870.25. The company's stock had a trading volume of 1,353,169 shares, compared to its average volume of 1,047,720. The company has a market capitalization of $114.09 billion, a price-to-earnings ratio of 33.65, a price-to-earnings-growth ratio of 3.30 and a beta of 1.51. The stock's fifty day simple moving average is $945.44 and its 200-day simple moving average is $799.83. The company has a current ratio of 3.06, a quick ratio of 2.02 and a debt-to-equity ratio of 0.61. Lam Research Co. has a 1 year low of $493.42 and a 1 year high of $1,007.39.

Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings data on Wednesday, January 24th. The semiconductor company reported $7.52 EPS for the quarter, topping analysts' consensus estimates of $7.06 by $0.46. Lam Research had a net margin of 24.15% and a return on equity of 44.47%. The business had revenue of $3.76 billion during the quarter, compared to analysts' expectations of $3.71 billion. During the same period last year, the company posted $10.71 EPS. The business's revenue was down 28.8% on a year-over-year basis. Analysts forecast that Lam Research Co. will post 28.9 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were paid a $2.00 dividend. This represents a $8.00 annualized dividend and a dividend yield of 0.92%. The ex-dividend date was Tuesday, March 12th. Lam Research's payout ratio is 30.94%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.